NTU Hospital Unveils AI Liquid Biopsy for Pancreatic Cancer with Over 93% Accuracy

Pancreatic cancer, often called the "King of Cancers," is notoriously difficult to detect early, with 85% of cases diagnosed at advanced stages. National Taiwan University (NTU) Hospital, in collaboration with Academia Sinica, has developed PanMETAI, an AI-driven diagnostic tool that requires only 0.1ml of blood to detect the disease.